Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects

Tissue Engineering - Part A

Volumn 16, Issue 12, 2010, Pages 3555-3568

  Kretlow, James D ^a   Spicer, Patrick P ^a   Jansen, John A ^b   Vacanti, Charles A ^c   Kasper, F Kurtis ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; BODY FLUIDS; BONE; COMPUTERIZED TOMOGRAPHY; DEFECTS; FLOWCHARTING; GLUES; GLUING; HISTOLOGY; HYDROGELS; HYDROXYAPATITE; LACTIC ACID; SCAFFOLDS; STEM CELLS; TISSUE ENGINEERING;

BONE FORMATION; BONE MARROW; BONE REGENERATION; BONE TISSUE ENGINEERING; BONE VOLUME; CELL-FREE; EX-VIVO; FIBRIN GLUE; FULL FACTORIAL; MESENCHYMAL STEM CELL; MICROCOMPUTED TOMOGRAPHY; MONONUCLEAR CELLS; PLATELET-RICH PLASMA; POLY L LACTIC ACID; POROUS SCAFFOLD; PUSH-OUT;

CELL CULTURE;

ANTHOZOA; RATTUS;

FIBRIN GLUE; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BONE MARROW CELL; BONE REGENERATION; CHEMISTRY; CYTOLOGY; FISCHER 344 RAT; HYDROGEL; MALE; METHODOLOGY; PHYSIOLOGY; RAT; SKULL; TISSUE ENGINEERING;

ANIMALS; BONE MARROW CELLS; BONE REGENERATION; FIBRIN TISSUE ADHESIVE; HYDROGELS; MALE; RATS; RATS, INBRED F344; SKULL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 78650056508     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0471     Document Type: Article

References (115)

1. Porada, C.D., Zanjani, E.D., and Almeida-Porad, G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 1, 365, 2006.
2. Liu, G., Li, Y., Sun, J., Zhou, H., Zhang, W., Cui, L., et al. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A 16, 971, 2010.
3. Guo, X., Park, H., Young, S., Kretlow, J.D., van den Beucken, J.J., Baggett, L.S., et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsu- lating marrow mesenchymal stem cells in a rabbit model. Acta Biomater 6, 39, 2010.
4. Macchiarini, P., Jungebluth, P., Go, T., Asnaghi, M.A., Rees, L.E., Cogan, T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023, 2008.
5. Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54, 2277, 2009.
6. Satar, B., Karahatay, S., Kurt, B., Ural, A.U., Safali, M., Avcu, F., et al. Repair of transected facial nerve with mes-enchymal stromal cells: histopathologic evidence of superior outcome. Laryngoscope 119, 2221, 2009.
7. Oh, J.Y., Kim, M.K., Shin, M.S., Lee, H.J., Ko, J.H., Wee, W.R., et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 26, 1047, 2008.
8. Ringden, O., Uzunel, M., Sundberg, B., Lonnies, L., Nava, S., Gustafsson, J., et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneu-momediastinum and perforated colon. Leukemia 21, 2271, 2007.
9. Kuo, Y.R., Goto, S., Shih, H.S., Wang, F.S., Lin, C.C., Wang, C.T., et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 87, 1769, 2009.
10. Giordano, A., Galderisi, U., and Marino, I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211, 27, 2007.
11. Sensebe, L. Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18, S3, 2008.
12. Frohlich, M., Grayson, W.L., Wan, L.Q., Marolt, D., Drob-nic, M., and Vunjak-Novakovic, G. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther 3, 254, 2008.
13. Sensebe, L., and Bourin, P. Producing MSC according GMP: process and controls. Biomed Mater Eng 18, 173, 2008.
14. Brinchmann, J.E. Expanding autologous multipotent mes-enchymal bone marrow stromal cells. J Neurol Sci 265, 127, 2008.
15. Pountos, I., Corscadden, D., Emery, P., and Giannoudis, P.V. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury 38 Suppl 4, S23, 2007.
16. Lange, C., Cakiroglu, F., Spiess, A.N., Cappallo-Obermann, H., Dierlamm, J., and Zander, A.R. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213, 18, 2007.
17. Schuh, E.M., Friedman, M.S., Carrade, D.D., Li, J., Heeke, D., Oyserman, S.M., et al. Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood. Am J Vet Res 70, 1526, 2009.
18. Frith, J.E., Thomson, B., and Genever, P. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16, 735, 2010.
19. Oedayrajsingh-Varma, M.J., Van Ham, S.M., Knippenberg, M., Helder, M.N., Klein-Nulend, J., Schouten, T.E., et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8, 166, 2006.
20. Seeger, F.H., Tonn, T., Krzossok, N., Zeiher, A.M., and Dimmeler, S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28, 766, 2007.
21. Agata, H., Asahina, I., Watanabe, N., Ishii, Y., Kubo, N., Ohshima, S., et al. Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. Tissue Eng Part A 16, 663, 2010.
22. Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G., and Kassem, M. Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies? Exp Ger-ontol 43, 1018, 2008.
23. Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., and Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28, 707, 2000.
24. Boquest, A.C., Shahdadfar, A., Fronsdal, K., Sigurjonsson, O., Tunheim, S.H., Collas, P., et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 16, 1131, 2005.
25. Centeno, C.J., Schultz, J.R., Cheever, M., Robinson, B., Freeman, M., and Marasco, W. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 5, 81, 2010.
26. Foudah, D., Redaelli, S., Donzelli, E., Bentivegna, A., Mi-loso, M., Dalpra, L., et al. Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res 17, 1025, 2009.
27. Duggal, S., Fronsdal, K.B., Szoke, K., Shahdadfar, A., Melvik, J.E., and Brinchmann, J.E. Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds. Tissue Eng Part A 15, 1763, 2009.
28. Kuhn, N.Z., and Tuan, R.S. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 222, 268, 2010.
29. Zhou, Y.F., Bosch-Marce, M., Okuyama, H., Krishna-machary, B., Kimura, H., Zhang, L., et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res 66, 10849, 2006.
30. Dahl, J.A., Duggal, S., Coulston, N., Millar, D., Melki, J., Shahdadfar, A., et al. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 52, 1033, 2008.
31. Stenderup, K., Justesen, J., Clausen, C., and Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919, 2003.
32. Aalami, O.O., Nacamuli, R.P., Lenton, K.A., Cowan, C.M., Fang, T.D., Fong, K.D., et al. Applications of a mouse model of calvarial healing: differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg 114, 713, 2004.
33. Shi, Y.Y., Nacamuli, R.P., Salim, A., and Longaker, M.T. The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg 116, 1686, 2005.
34. Crisostomo, P.R., Markel, T.A., Wang, M., Lahm, T., Lillemoe, K.D., and Meldrum, D.R. In the adult mesen-chymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 142, 215, 2007.
35. Siddappa, R., Licht, R., van Blitterswijk, C, and de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25, 1029, 2007.
36. Kretlow, J.D., Jin, Y.Q., Liu, W., Zhang, W.J., Hong, T.H., Zhou, G., et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 9, 60, 2008.
37. McCann, R.M., Marsh, D.R., Horner, A., and Clarke, S. Body mass index is more predictive of progenitor number in bone marrow stromal cell population than age in males- expanding the predictors of the progenitor compartment. Tissue Eng Part A 16, 889, 2010.
38. Iwase, T., Nagaya, N., Fujii, T., Itoh, T., Murakami, S., Matsumoto, T., et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells inarat model of hindlimb ischemia. Cardiovasc Res 66, 543, 2005.
39. Mazo, M., Gavira, J.J., Abizanda, G., Moreno, C., Ecay, M., Soriano, M., et al. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant 19, 313, 2010.
40. Samdani, A.F., Paul, C., Betz, R.R., Fischer, I., and Neu-huber, B. Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study. Spine (Phila Pa 1976) 34, 2605, 2009.
41. Okumura, M., Ohgushi, H., and Tamai, S. Bonding osteo-genesis in coralline hydroxyapatite combined with bone marrow cells. Biomaterials 12, 411, 1991.
42. Ohgushi, H., Okumura, M., Tamai, S., Shors, E.C., and Caplan, A.I. Marrow cell induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: a comparative histomorphometric study of ectopic bone formation. J Biomed Mater Res 24, 1563, 1990.
43. Ohgushi, H., Goldberg, V.M., and Caplan, A.I. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 7, 568, 1989.
44. Chang, F., Ishii, T., Yanai, T., Mishima, H., Akaogi, H., Ogawa, T., et al. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res 26, 18, 2008.
45. Gan, Y., Dai, K., Zhang, P., Tang, T., Zhu, Z., and Lu, J. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials 29, 3973, 2008.
46. Muschler, G.F., Matsukura, Y., Nitto, H., Boehm, C.A., Valdevit, A.D., Kambic, H.E., et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res (432), 242, 2005.
47. Dean, D., Wolfe, M.S., Ahmad, Y., Totonchi, A., Chen, J.E., Fisher, J.P., et al. Effect of transforming growth factor beta 2 on marrow-infused foam poly(propylene fumarate) tissue-engineered constructs for the repair of critical-size cranial defects in rabbits. Tissue Eng 11, 923, 2005.
48. Ryu, J.H., Kim, I.K., Cho, S.W., Cho, M.C., Hwang, K.K., Piao, H., et al. Implantation of bone marrow mono-nuclear cells using injectable fibrin matrix enhances neo-vascularization in infarcted myocardium. Biomaterials 26, 319, 2005.
49. Falanga, V., Iwamoto, S., Chartier, M., Yufit, T., Butmarc, J., Kouttab, N., et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13, 1299, 2007.
50. Kalbermatten, D.F., Kingham, P.J., Mahay, D., Mantovani, C., Pettersson, J., Raffoul, W., et al. Fibrin matrix for suspension of regenerative cells in an artificial nerve conduit. J Plast Reconstr Aesthet Surg 61, 669, 2008.
51. Vacanti, C.A., Bonassar, L.J., Vacanti, M.P., and Shuf-flebarger, J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344, 1511, 2001.
52. Behravesh, E., and Mikos, A.G. Three-dimensional culture of differentiating marrow stromal osteoblasts in biomi-metic poly(propylene fumarate-co-ethylene glycol)-based macroporous hydrogels. J Biomed Mater Res A 66, 698, 2003.
53. Trojani, C., Boukhechba, F., Scimeca, J.C., Vandenbos, F., Michiels, J.F., Daculsi, G., et al. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 27, 3256, 2006.
54. Vadala, G., Di Martino, A., Tirindelli, M.C., Denaro, L., and Denaro, V. Use of autologous bone marrow cells concentrate enriched with platelet-rich fibrin on corticocancellous bone allograft for posterolateral multilevel cervical fusion. J Tissue Eng Regen Med 2, 515, 2008.
55. Catelas, I., Sese, N., Wu, B.M., Dunn, J.C.Y., Helgerson, S., and Tawil, B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 12, 2385, 2006.
56. Ho, W., Tawil, B., Dunn, J.C.Y., and Wu, B.M. The behavior of human mesenchymal stem cells in 3d fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12, 1587, 2006.
57. Fernandes, H., Dechering, K., Van Someren, E., Steeghs, I., Apotheker, M., Leusink, A., et al. The role of collagen crosslinking in differentiation of human mesenchymal stem cells and MC3T3-E1 cells. Tissue Eng Part A 15, 3857, 2009.
58. Elgazzar, R.F., Mutabagani, M.A., Abdelaal, S.E., and Sa-dakah, A.A. Platelet rich plasma may enhance peripheral nerve regeneration after cyanoacrylate reanastomosis: a controlled blind study on rats. Int J Oral Maxillofac Surg 37, 748, 2008.
59. Ellis, B.C., and Stransky, A. A quick and accurate method for the determination of fibronogen in plasma. J Lab Clin Med 58, 477, 1961.
60. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
61. Dhert, W.J., Verheyen, C.C., Braak, L.H., de Wijn, J.R., Klein, C.P., De Groot, K., et al. A finite element analysis of the push-out test: influence of test conditions. J Biomed Mater Res 26, 119, 1992.
62. Young, S., Patel, Z.S., Kretlow, J.D., Murphy, M.B., Mountziaris, P.M., Baggett, L.S., et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15, 2347, 2009.
63. Amling, M., Priemel, M., Holzmann, T., Chapin, K., Rue-ger, J.M., Baron, R., et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140, 4982, 1999.
64. Glantz, S.A. Primer of Biostatistics, 6th edition. New York: McGraw-Hill Medical, 2005.
65. Shah, D.A., and Madden, L.V. Nonparametric analysis of ordinal data in designed factorial experiments. Phytopathology 94, 33, 2004.
66. Brunner, E., Dette, H., and Munk, A. Box-type approximations in nonparametric factorial designs. J Am Stat As-soc 92, 1494, 1997.
67. Klouda, L., Kretlow, J.D., and Mikos, A. Tailored bioma-terials for tissue engineering needs and their clinical translation. In: Mao, J.J., Vunjak-Novakovic, G., Mikos, A.G., and Atala, A., eds. Translational Approaches in Tissue Engineering and Regenerative Medicine, 1st edition. Boston, MA: Artech House, 2008, pp. 325-337.
68. Li, W.J., Cooper, J.A., Jr., Mauck, R.L., and Tuan, R.S. Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater 2, 377, 2006.
69. Yoon, E., Dhar, S., Chun, D.E., Gharibjanian, N.A., and Evans, G.R. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 13, 619, 2007.
70. Abramovitch-Gottlib, L., Geresh, S., and Vago, R. Biofab-ricated marine hydrozoan: a bioactive crystalline material promoting ossification of mesenchymal stem cells. Tissue Eng 12, 729, 2006.
71. Mygind, T., Stiehler, M., Baatrup, A., Li, H., Zou, X., Flyvbjerg, A., et al. Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Bio-materials 28, 1036, 2007.
72. Flautre, B., Descamps, M., Delecourt, C., Blary, M.C., and Hardouin, P. Porous HA ceramic for bone replacement: role of the pores and interconnections - experimental study in the rabbit. J Mater Sci Mater Med 12, 679, 2001.
73. Harris, C.T., and Cooper, L.F. Comparison of bone graft matrices for human mesenchymal stem cell-directed os-teogenesis. J Biomed Mater Res A 68, 747, 2004.
74. Plachokova, A.S., van den Dolder, J., Stoelinga, P.J., and Jansen, J.A. The bone regenerative effect of platelet-rich plasma in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res 17, 305, 2006.
75. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
76. Kroese-Deutman, H.C., Vehof, J.W.M., Spauwen, P.H.M., Stoelinga, P.J.W., and Jansen, J.A. Orthotopic bone formation in titanium fiber mesh loaded with platelet-rich plasma and placed in segmental defects. Int J Oral Maxillofac Surg 37, 542, 2008.
77. Messora, M.R., Nagata, M.J., Mariano, R.C., Dornelles, R.C., Bomfim, S.R., Fucini, S.E., et al. Bone healing in critical-size defects treated with platelet-rich plasma: a histologic and histometric study in rat calvaria. J Perio-dontal Res 43, 217, 2008.
78. Fontana, S., Olmedo, D.G., Linares, J.A., Guglielmotti, M.B., and Crosa, M.E. Effect of platelet-rich plasma on the peri-implant bone response: an experimental study. Implant Dent 13, 73, 2004.
79. Filho Cerruti, H., Kerkis, I., Kerkis, A., Tatsui, N.H., da Costa Neves, A., Bueno, D.F., et al. Allogenous bone grafts improved by bone marrow stem cells and platelet growth factors: clinical case reports. Artif Organs 31, 268, 2007.
80. Hu, Z.M., Peel, S.A., Ho, S.K., Sandor, G.K., and Clokie, C.M. Comparison of platelet-rich plasma, bovine BMP, and rhBMP-4 on bone matrix protein expression in vitro. Growth Factors 27, 280, 2009.
81. van den Dolder, J., Mooren, R., Vloon, A.P., Stoelinga, P.J., and Jansen, J.A. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12, 3067, 2006.
82. Roldan, J.C., Jepsen, S., Miller, J., Freitag, S., Rueger, D.C., Acil, Y., et al. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 34, 80, 2004.
83. Arpornmaeklong, P., Kochel, M., Depprich, R., Kubler, N.R., and Wurzler, K.K. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 33, 60, 2004.
84. Leitner, G.C., Gruber, R., Neumuller, J., Wagner, A., Kloimstein, P., Hocker, P., et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang 91, 135, 2006.
85. Kevy, S.V., and Jacobson, M.S. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol 36, 28, 2004.
86. Weibrich, G., Kleis, W.K., Hitzler, W.E., and Hafner, G. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth- factors kit to produce platelet-rich plasma: a technical report. Int J Oral Maxillofac Implants 20, 118, 2005.
87. Kim, E.S., Park, E.J., and Choung, P.H. Platelet concentration and its effect on bone formation in calvarial defects: an experimental study in rabbits. J Prosthet Dent 86, 428, 2001.
88. Weibrich, G., Kleis, W.K., Kunz-Kostomanolakis, M., Loos, A.H., and Wagner, W. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Int J Oral Maxillofac Implants 16, 693, 2001.
89. Weibrich, G., Hansen, T., Kleis, W., Buch, R., and Hitzler, W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 34, 665, 2004.
90. Plachokova, A.S., van den Dolder, J., van den Beucken, J.J., and Jansen, J.A. Bone regenerative properties of rat, goat and human platelet-rich plasma. Int J Oral Maxillofac Surg 38, 861, 2009.
91. Kasten, P., Vogel, J., Luginbuhl, R., Niemeyer, P., Weiss, S., Schneider, S., et al. Influence of platelet-rich plasma on os-teogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs 183, 68, 2006.
92. Kasten, P., Vogel, J., Beyen, I., Weiss, S., Niemeyer, P., Leo, A., et al. Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesen-chymal stem cells on distinct calcium phosphate scaffolds: the specific surface area makes a difference. J Biomater Appl 23, 169, 2008.
93. Tasso, R., Augello, A., Boccardo, S., Salvi, S., Carida, M., Postiglione, F., et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 15, 2203, 2009.
94. Le Nihouannen, D., Goyenvalle, E., Aguado, E., Pilet, P., Bilban, M., Daculsi, G., et al. Hybrid composites of calcium phosphate granules, fibrin glue, and bone marrow for skeletal repair. J Biomed Mater Res A 81, 399, 2007.
95. Ueno, T., Honda, K., Hirata, A., Kagawa, T., Kanou, M., Shirasu, N., et al. Histological comparison of bone induced from autogenously grafted periosteum with bone induced from autogenously grafted bone marrow in the rat calvarial defect model. Acta Histochem 110, 217, 2008.
96. Becker, S., Maissen, O., Ponomarev, I., Stoll, T., Rahn, B., and Wilke, I. Osteopromotion by a beta-tricalcium phosphate/bone marrow hybrid implant for use in spine surgery. Spine (Phila Pa 1976) 31, 11, 2006.
97. Zhang, G., Drinnan, C.T., Geuss, L.R., and Suggs, L.J. Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. Acta Bio-mater 6, 3395, 2010.
98. Zhang, G., Hu, Q., Braunlin, E.A., Suggs, L.J., and Zhang, J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng Part A 14, 1025, 2008.
99. Drinnan, C.T., Zhang, G., Alexander, M.A., Pulido, A.S., and Suggs, L.J. Multimodal release of transforming growth factor-beta1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J Control Release 2010. [Epub ahead of print].
100. Zhang, G., Wang, X., Wang, Z., Zhang, J., and Suggs, L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng 12, 9, 2006.
101. Zhu, S.J., Choi, B.H., Jung, J.H., Lee, S.H., Huh, J.Y., You, T.M., et al. A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102, 175, 2006.
102. Findikcioglu, K., Findikcioglu, F., Yavuzer, R., Elmas, C., and Atabay, K. Effect of platelet-rich plasma and fibrin glue on healing of critical-size calvarial bone defects. J Craniofac Surg 20, 34, 2009.
103. Ito, K., Yamada, Y., Naiki, T., and Ueda, M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res 17, 579, 2006.
104. Tsai, C.H., Hsu, H.C., Chen, Y.J., Lin, M.J., and Chen, H.T. Using the growth factors-enriched platelet glue in spinal fusion and its efficiency. J Spinal Disord Tech 22, 246, 2009.
105. Lee, L.T., Kwan, P.C., Chen, Y.F., and Wong, Y.K. Comparison of the effectiveness of autologous fibrin glue and macroporous biphasic calcium phosphate as carriers in the osteogenesis process with or without mesenchymal stem cells. J Chin Med Assoc 71, 66, 2008.
106. Kalia, P., Coathup, M.J., Oussedik, S., Konan, S., Dodd, M., Haddad, F.S., et al. Augmentation of bone growth onto the acetabular cup surface using bone marrow stromal cells in total hip replacement surgery. Tissue Eng Part A 15, 3689, 2009.
107. Lucarelli, E., Fini, M., Beccheroni, A., Giavaresi, G., Di Bella, C., Aldini, N.N., et al. Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Or-thop Relat Res (435), 62, 2005.
108. Yamada, Y., Ueda, M., Naiki, T., Takahashi, M., Hata, K., and Nagasaka, T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10, 955, 2004.
109. Lei, H., Xiao, R., Tang, X.J., and Gui, L. Evaluation of the efficacy of platelet-rich plasma in delivering BMSCs into 3D porous scaffolds. J Biomed Mater Res B Appl Biomater 91B, 679, 2009.
110. Giannoni, P., Scaglione, S., Daga, A., Ilengo, C., Cilli, M., and Quarto, R. Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. Tissue Eng Part A 16, 489, 2010.
111. Haasper, C., Breitbart, A., Hankemeier, S., Wehmeier, M., Hesse, E., Citak, M., et al. Influence of fibrin glue on proliferation and differentiation of human bone marrow stro-mal cells seeded on a biologic 3-dimensional matrix. Technol Health Care 16, 93, 2008.
112. Patel, V.V., Zhao, L., Wong, P., Pradhan, B.B., Bae, H.W., Kanim, L., et al. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Spine J 6, 397, 2006; discussion 4.
113. Woodruff, M.A., Rath, S.N., Susanto, E., Haupt, L.M., Hutmacher, D.W., Nurcombe, V., et al. Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model. J Mol Histol 38, 425, 2007.
114. Hou, T., Xu, J., Li, Q., Feng, J., and Zen, L. In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. Tissue Eng Part A 14, 1173, 2008.
115. Bensaid, W., Triffitt, J.T., Blanchat, C., Oudina, K., Sedel, L., and Petite, H. A biodegradable fibrin scaffold for mes-enchymal stem cell transplantation. Biomaterials 24, 2497, 2003.